IL-32 is induced by activation of toll-like receptors in multiple myeloma cells

IL-32 is induced by activation of toll-like receptors in multiple myeloma cells

Multiple myeloma (MM) is a hematological cancer characterized by accumulation of malignant plasma cells in the bone marrow. The patients are immune suppressed and suffer from recurrent and chronic infections. Interleukin-32 is a non-conventional, pro-inflammatory cytokine expressed in a subgroup of...

Full description

Bibliographic Details
Main Authors:	Kristin Roseth Aass, Synne Stokke Tryggestad, Robin Mjelle, Martin H. Kastnes, Tonje Marie Vikene Nedal, Kristine Misund, Therese Standal
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Immunology
Subjects:	multiple myeloma TLR inflammation IL-32 NFκB cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1107844/full

Similar Items

Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
by: Kristin Roseth Aass, et al.
Published: (2022-07-01)

The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
by: Martin Kastnes, et al.
Published: (2023-05-01)

Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells
by: Kristin Roseth Aass, et al.
Published: (2022-01-01)

Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma
by: Tonje Marie Vikene Nedal, et al.
Published: (2024-02-01)

sMETASeq: Combined Profiling of Microbiota and Host Small RNAs
by: Robin Mjelle, et al.
Published: (2020-05-01)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
by: Anne Marit Sponaas, et al.
Published: (2021-02-01)

Automated Quantification of Human Osteoclasts Using Object Detection
by: Sampsa Kohtala, et al.
Published: (2022-07-01)

Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
by: Yang Liu, et al.
Published: (2022-12-01)

Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location
by: Robin Mjelle, et al.
Published: (2019-02-01)

Prognostic value of 13q14 deletion and IgH 14q32 rearrangement by interphase fluorescence in situ hybridization in patients with multiple myeloma
by: Nevine A Kassem, et al.
Published: (2014-01-01)

Toll-like receptor 6 inhibits colorectal cancer progression by suppressing NF-κB signaling
by: Lina Ma, et al.
Published: (2024-03-01)

Toll-like receptor 3 modulates the behavioral effects of cocaine in mice
by: Ruiming Zhu, et al.
Published: (2018-03-01)

Subverting Toll-like receptor signalling by bacterial pathogens
by: Victoria eMcGuire, et al.
Published: (2015-12-01)

Cellulose alters the expression of nuclear factor kappa B-related genes and Toll-like receptor-related genes in human peripheral blood mononuclear cells
by: Leonie M. Vogt, et al.
Published: (2015-10-01)

Çeşitli Hastalıklarda Toll Benzeri Reseptörlerin Rolü
by: Berrak Güven, et al.
Published: (2012-03-01)

Palmitate Stimulates Expression of the von Willebrand Factor and Modulates Toll-like Receptors Level and Activity in Human Umbilical Vein Endothelial Cells (HUVECs)
by: Agnieszka K. Seliga, et al.
Published: (2023-12-01)

AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation
by: Rongfang Wei, et al.
Published: (2022-11-01)

Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors
by: Alexis A. Hatton, et al.
Published: (2022-12-01)

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells
by: Cesarina Giallongo, et al.
Published: (2020-07-01)

Toll-like receptor 4 deficiency in mice impairs venous thrombus resolution
by: Haixin Yuan, et al.
Published: (2023-05-01)

Serum free light-chain concentration and relationship with some characteristics of patients with multiple myeloma
by: Van Nguyen-Thanh Phan, et al.
Published: (2023-01-01)

Massive pleural effusion due to IgG multiple myeloma
by: Kathryn Jane Lang, et al.
Published: (2009-11-01)

TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment
by: Grazia Scandura, et al.
Published: (2022-04-01)

Stimulation of monocytes by placental microparticles involves Toll-like receptors and nuclear factor kappa-light-chain-enhancer of activated B cells
by: Marianne Simone Joerger-Messerli, et al.
Published: (2014-04-01)

Toll-like receptor 2-mediated NF-kappa B pathway activation in ocular surface epithelial cells
by: Aihua Hou, et al.
Published: (2017-07-01)

Lipophosphoglycan From Dermotropic New World Leishmania Upregulates Interleukin-32 and Proinflammatory Cytokines Through TLR4 and NOD2 Receptors
by: Murilo Barros Silveira, et al.
Published: (2022-03-01)

Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis
by: Elisabetta Vulpis, et al.
Published: (2017-03-01)

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway
by: Xuejie Gao, et al.
Published: (2021-05-01)

Role and Modulation of NK Cells in Multiple Myeloma
by: Marie Thérèse Rubio, et al.
Published: (2021-04-01)

Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
by: Thomas Smol, et al.
Published: (2017-07-01)

The role of Toll-like receptors in chemoradiotherapy-induced gastrointestinal mucositis
by: JI Ling, et al.
Published: (2021-02-01)

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
by: Thomas A. Burley, et al.
Published: (2022-03-01)

Inhibition of proprotein convertase subtilisin/kexin type 9 attenuates 2,4,6‐trinitrobenzenesulfonic acid‐induced colitis via repressing toll‐like receptor 4/nuclear factor‐kappa B
by: Lei Lei, et al.
Published: (2020-09-01)

Sulfatide Inhibits HMGB1 Secretion by Hindering Toll-Like Receptor 4 Localization Within Lipid Rafts
by: Hee Sue Kim, et al.
Published: (2020-06-01)

Elevated expression of Toll-like receptor 4 and cytokines in both serum and myometrium at term may serve as promising biomarkers for uterine activation preceding labor
by: Zixi Chen, et al.
Published: (2023-10-01)

JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ
by: Zilu Zhang, et al.
Published: (2022-05-01)

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma
by: Muthu K. Shanmugam, et al.
Published: (2018-05-01)

Targeting NF-κB Signaling for Multiple Myeloma
by: Ada Hang-Heng Wong, et al.
Published: (2020-08-01)

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment
by: Anine Larsen Ottestad, et al.
Published: (2022-12-01)

Major gene expression changes and epigenetic remodelling in Nile tilapia muscle after just one generation of domestication
by: Ioannis Konstantinidis, et al.
Published: (2020-10-01)